Skip to content

Biodesix, Inc. BDSX Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$7.79M-95.8%-$3.98M+54.3%-$8.72M+24.0%-$11.47M-3.3%-$11.1M-34.5%
$1.4M+0.6%$1.39M-1.4%$1.41M-2.1%$1.44M-0.3%$1.44M-0.6%
$1.12M+3.7%$1.08M+2.1%$1.05M+1.3%$1.04M+6.9%$972K-23.2%
-$10.17M$0+100%-$8.88M-35.2%-$6.57M+23.6%-$8.6M-110%
$81K-5.8%$86K+79.2%$48K-5.9%$51K-31.1%$74K-91.2%
-$144K-38.5%-$104K-55.2%-$67K+29.5%-$95K+30.7%-$137K+84.5%
$5K0.0%$5K+25.0%$4K-20.0%$5K-28.6%$7K-46.2%
$16.9M+889%$1.71M-64.6%$4.82M-50.7%$9.79M+9,992%$97K
$6.59M-$4.12M-$8.64M-67.4%
-$10.25M$0+100%-$8.93M-34.9%-$6.62M+23.7%-$8.68M-75.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Biodesix, Inc. generate?
Biodesix, Inc. (BDSX) generated -$25.6M in operating cash flow over the trailing twelve months.
What is Biodesix, Inc.'s free cash flow?
After $266.0K of capital expenditures, Biodesix, Inc.'s free cash flow was -$25.8M over the trailing twelve months, up 42.7% year over year.
Where does Biodesix, Inc.'s cash flow data come from?
Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.